| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
group | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
group | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 2 | 0.769 | 0.154 | 0.75 |
|
group | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | ||||||||
|
chromosome 5 open reading frame 66 | 0.760 | 0.154 | 5.3E-04 |
|
group | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | ||||||||
|
CCND2 antisense RNA 1 | 0.760 | 0.154 |
|
group | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | |||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
group | 0.100 | None | 1.000 | 6 | 2 | 2015 | 2019 | ||||||||
|
ZMIZ1 antisense RNA 1 | 0.780 | 0.115 |
|
group | 0.100 | None | 1.000 | 6 | 1 | 2014 | 2019 | |||||||||
|
transmembrane protein 258 | 0.644 | 0.654 | 1.9E-03 |
|
group | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
myelin regulatory factor | 0.584 | 0.731 | 1.00 |
|
group | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 | 0.644 | 0.615 | 1.00 |
|
group | 0.100 | None | 1.000 | 4 | 1 | 2015 | 2019 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
group | 0.100 | None | 1.000 | 4 | 1 | 2015 | 2019 | ||||||||
|
laminin subunit gamma 1 | 0.628 | 0.654 | 1.00 |
|
group | 0.100 | None | 1.000 | 4 | 3 | 2013 | 2019 | ||||||||
|
PNKD metallo-beta-lactamase domain containing | 0.615 | 0.615 | 4.1E-08 |
|
group | 0.100 | None | 1.000 | 4 | 3 | 2018 | 2019 | ||||||||
|
laminin subunit alpha 5 | 0.636 | 0.577 | 6.5E-03 |
|
group | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2019 | ||||||||
|
Cdk5 and Abl enzyme substrate 2 | 0.805 | 0.077 | 2.1E-04 |
|
group | 0.100 | None | 1.000 | 3 | 1 | 2014 | 2019 | ||||||||
|
TMEM220 antisense RNA 1 | 0.792 | 0.077 |
|
group | 0.100 | None | 1.000 | 3 | 1 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1475 | 0.780 | 0.077 |
|
group | 0.100 | None | 1.000 | 3 | 2 | 2014 | 2019 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
group | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | |||||||||
|
TOX high mobility group box family member 2 | 0.736 | 0.154 | 3.2E-02 |
|
group | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
SMAD family member 6 | 0.579 | 0.731 | 3.6E-20 |
|
group | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 1500 | 0.760 | 0.192 |
|
group | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||||||
|
formin 1 | 0.686 | 0.423 | 3.6E-18 |
|
group | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 |